InnoAlliance

Discovery

At InnoAlliance, we understand the critical role of bioanalysis in the discovery phase of drug development. Our bioanalytical services are designed to provide comprehensive support for the identification and validation of new drug candidates. With a focus on precision and reliability, we help you uncover the pharmacokinetic (PK), pharmacodynamic (PD), and toxicokinetic (TK) profiles of novel molecules, ensuring a robust foundation for your preclinical and clinical strategies. We offer quick turnarounds with competitive pricing to meet your needs of agile development.

Capabilities

High-Volume Sample Analysis

Capable of processing thousands of samples per day.

Flexible Study Designs

Accommodating a range of study sizes, from small-scale pilot projects to extensive longitudinal studies.

Scalable Operations

Easily adjust to increasing workload demands without compromising on quality or timelines.

Quick turnaround with competitive pricing

Platforms

ELISA

MSD

Cell-Based Assays

LC-MS/MS

High-Resolution Mass Spectrometry

Flexible and robust. Supporting R&D affinity, PK, PD, and biomarker assays

Flagship multiplex immunoassay platform that’s ideal for simultaneous detection and qualitification of multiple biomarkers, supporting complex pharmacodynamic studies. Robust for PK and ADA assay support

Critical for assessing the biological activity and potency of compounds.

For precise quantification and robust analysis of small molecules and peptides.

Enables detailed molecular characterization and complex biomarker profiling.

Why do you need Discovery Services?

Expertise: Our team consists of industry-leading scientists with extensive experience in pharmacology, toxicology, and molecular biology.

Innovation: We continually invest in the latest technologies and methodologies to stay at the forefront of bioanalytical science.

Collaborative Approach: We work closely with our clients, ensuring transparency and continuous communication throughout the research process.